| goserelin acetate / Generic mfg. |
NCT00849082: Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer |
|
|
| Completed | 3 | | US | cyproterone acetate, goserelin acetate, radiation therapy | European Organisation for Research and Treatment of Cancer - EORTC | Prostate Cancer | 11/95 | | | |
| Completed | 3 | | US | flutamide, goserelin acetate, leuprolide acetate, suramin, therapeutic hydrocortisone, orchiectomy | Eastern Cooperative Oncology Group, National Cancer Institute (NCI), Cancer and Leukemia Group B, Southwest Oncology Group | Prostate Cancer | 04/98 | | | |
NCT00841113: Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer |
|
|
| Completed | 3 | 177 | Europe | Abarelix, Plenaxis, Goserelin plus Bicalutamide | Speciality European Pharma Limited | Prostate Cancer | 02/01 | 02/03 | | |
NCT00769548: Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer |
|
|
| Completed | 3 | 1322 | US | flutamide, goserelin acetate, low-LET photon therapy, radiation therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI) | Prostate Cancer | 04/01 | 12/16 | | |
NCT01394263: Study of Histrelin Subdermal Implant in Patients With Prostate Cancer |
|
|
| Completed | 3 | 59 | NA | Histrelin hydrogel implant, Vantas, Zoladex goserelin implant, Zoladex | Endo Pharmaceuticals | Prostate Cancer, Adenocarcinoma of the Prostate | 12/01 | 12/03 | | |
NCT00014586: Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer |
|
|
| Terminated | 3 | 110 | Europe | bicalutamide, goserelin acetate, orchiectomy | European Organisation for Research and Treatment of Cancer - EORTC | Prostate Cancer | 02/03 | | | |
NCT00767286: Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer |
|
|
| Completed | 3 | | US | flutamide, goserelin acetate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI) | Prostate Cancer | | 11/03 | | |
NCT00067015: Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer |
|
|
| Completed | 3 | 3 | US | bicalutamide, goserelin acetate, assessment of therapy complications, quality-of-life assessment, radiation therapy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Prostate Cancer | 10/04 | 09/08 | | |
NCT00004635: Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer |
|
|
| Completed | 3 | 159 | US | Thalidomide, Thalomid, leuprolide acetate, leuprorelin, goserelin, Zolodex, Placebo, Sugar pill | National Cancer Institute (NCI), Holy Cross Hospital, Fort Lauderdale, Louisiana State University Health Sciences Center in New Orleans, Wayne State University, University of Minnesota, Columbia University, University of Pittsburgh, United States Naval Medical Center, Portsmouth, University of Washington | Prostate Cancer | 01/05 | 03/10 | | |
NCT00021450: Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer |
|
|
| Completed | 3 | 819 | Europe, RoW | bicalutamide, goserelin acetate, adjuvant therapy, radiation therapy | European Organisation for Research and Treatment of Cancer - EORTC | Prostate Cancer | 04/08 | 01/16 | | |
| Terminated | 3 | 42 | Europe | Degarelix, FE200486, Goserelin, Zoladex, Bicalutamide, Casodex | Ferring Pharmaceuticals | Prostate Cancer | 06/10 | 07/10 | | |
| Completed | 3 | 859 | US, Canada, Europe, RoW | Degarelix, Firmagon, FE200486, Goserelin acetate, Zoladex | Ferring Pharmaceuticals | Prostate Cancer | 03/11 | 03/11 | | |
| Completed | 3 | 182 | Europe, RoW | Degarelix, FE200486, FIRMAGON, Goserelin, ZOLADEX, Bicalutamide, CASODEX | Ferring Pharmaceuticals | Prostate Cancer | 03/11 | 03/11 | | |
NCT00388804: External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer |
|
|
| Terminated | 3 | 39 | US | Radiation Therapy, RT, XRT, Bicalutamide, Casodex, Leuprolide, Lupron, Goserelin, Zoladex, Flutamide, Questionnaire, Survey | M.D. Anderson Cancer Center | Prostate Cancer | 04/11 | 04/11 | | |
NCT00002597: Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer |
|
|
| Completed | 3 | 2028 | Canada, US | flutamide, Eulexin, Zoladex, goserelin acetate, Lupron, leuprolide acetate, radiation therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI) | Prostate Cancer | 07/11 | 05/18 | | |
| Completed | 3 | 246 | US, Europe | Degarelix, FE200486, Firmagon, Goserelin, Zoladex, Bicalutamide, Casodex | Ferring Pharmaceuticals | Prostate Cancer | 09/11 | 09/11 | | |
| Terminated | 3 | 288 | US, Canada, Europe, RoW | Degarelix, Firmagon, FE200486, Goserelin acetate, Zoladex | Ferring Pharmaceuticals | Prostate Cancer | 12/11 | 01/12 | | |
| Completed | 3 | 3040 | Canada | bicalutamide, goserelin acetate, clinical observation | Southwest Oncology Group, National Cancer Institute (NCI), NCIC Clinical Trials Group, Cancer and Leukemia Group B, Eastern Cooperative Oncology Group, European Organisation for Research and Treatment of Cancer - EORTC | Prostate Cancer | 06/13 | 06/13 | | |
CRUK-OPTION, NCT00427245: Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer |
|
|
| Completed | 3 | 400 | Europe | cyclophosphamide, goserelin acetate, adjuvant therapy, fertility assessment and management, neoadjuvant therapy | Anglo Celtic Cooperative Oncology Group | Breast Cancer, Infertility, Menopausal Symptoms | | | | |
NCT00423475: Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer |
|
|
| Completed | 3 | 743 | Europe | goserelin acetate, ZOLADEX, adjuvant therapy, radiation therapy | UNICANCER, AstraZeneca | Prostate Cancer | 03/15 | | | |
NCT01744366: One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population |
|
|
| Completed | 3 | 285 | RoW | Degarelix, Goserelin | Ferring Pharmaceuticals | Prostate Cancer | 05/15 | 05/15 | | |
ELAAT, NCT00439751: Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy |
|
|
| Completed | 3 | 79 | Canada | Goserelin Acetate, Zoladex®, Zoladex® LA | Ontario Clinical Oncology Group (OCOG), AstraZeneca | Prostate Cancer | 12/15 | 06/16 | | |
NCT02015871: An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer |
|
|
| Completed | 3 | 206 | RoW | Degarelix | Ferring Pharmaceuticals | Prostate Cancer | 08/17 | 08/17 | | |
NCT01603420: External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer |
|
|
| Terminated | 2/3 | 2 | US | Luteinizing hormone-releasing hormone (LHRH), -Androgen Suppression, -Androgen Deprivation, -Zoladex, -Lupron, -Eligard, -Viadur, Docetaxel, -taxotere, -docetaxel, Conformal Radiation Therapy (RT), Intensity-modulated Radiation Therapy (IMRT), Proton Therapy, Particle Therapy | Proton Collaborative Group | Prostate Cancer | 05/14 | 05/14 | | |
